new retatrutide 🎙️ EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in A New Obesity Drug Delivered

Patients receiving GLP-1 therapy demonstrated lower rates of advanced adenomas on surveillance colonoscopy, a finding particularly relevant given that adenoma prevention formed the evidentiary backbone for aspirins adoption in earlier prevention strategies

Over time, people with type 2 diabetes may also stop producing enough insulin

Allergic Reactions and Gastrointestinal Issues If you experience any allergic reactions or gastrointestinal issues, such as cramping, bloating, or diarrhea when taking glutathione supplements, its recommended to discontinue use and consult your healthcare provider

One complication is the presence of super-users of many fast-moving consumer goods